Zobrazeno 1 - 9
of 9
pro vyhledávání: '"A. Z. Maksyutov"'
Autor:
T. V. Bauer, T. V. Tregubchak, A. Z. Maksyutov, R. A. Maksyutov, I. V. Kolosova, E. V. Gavrilova
Publikováno v:
Вопросы вирусологии, Vol 65, Iss 1, Pp 49-56 (2020)
Introduction. Currently, new directions in cancer therapy are actively developing, one of which is oncolytic immunotherapy. This approach would be to use of viruses as cancer specific cytolytic agents capable of stimulating both the tumor-specific an
Externí odkaz:
https://doaj.org/article/ffc718de39d2444bac7b1da4a7bb4caf
Autor:
A. Z. Maksyutov, Yu. A. Lopatnikova, V. V. Kurilin, Yu. A. Shevchenko, Yu. N. Khantakova, E. V. Gavrilova, R. A. Maksyutov, A. G. Peregudov, S. A. Zaytsev, V. A. Kozlov, S. V. Sennikov
Publikováno v:
Медицинская иммунология, Vol 16, Iss 5, Pp 417-424 (2014)
This study describes a design of genetic constructs encoding either non-specific, or HLA-A *0201-specific polyepitopic immunogens containing antigenic determinants for HER2 protein. We have shown that transfection of mature dendritic cells by polyepi
Externí odkaz:
https://doaj.org/article/27bfad0017444550bbf58a5766869c9c
Autor:
Sergey V. Sennikov, Amir Z. Maksyutov, Vasiliy V. Kurilin, Maria S. Kuznetsova, Alexander N. Silkov, Julia N. Khantakova, Julia A. Lopatnikova, Julia A. Shevchenko
Publikováno v:
Frontiers in Bioscience-Landmark. 27:170
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ce57b5b060c41b44d48d4135c761246d
https://doi.org/10.31083/j.fbl2706170
https://doi.org/10.31083/j.fbl2706170
Autor:
Denis V. Antonets, A. Z. Maksyutov
Publikováno v:
Molecular Biology. 44:119-127
The program TEpredict was developed for T-cell epitope prediction. The used models for T-cell epitope prediction were constructed by the partial least squares regression method using the data extracted from the IEDB (Immune Epitope Database), the mos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48c434acc25d6d8de854fc8962eb2fac
https://doi.org/10.1134/s0026893310010152
https://doi.org/10.1134/s0026893310010152
Publikováno v:
Journal of medical virology. 87(7)
Approximately 2% and 5% of the world human population is estimated to be infected with HCV and HBV, respectively. Reference panels of HCV and HBV serum samples with defined genotypes and serotypes is necessary for monitoring of the specificity and se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35f917b6894a35a3fef2170ff56d9773
https://pubmed.ncbi.nlm.nih.gov/25758235
https://pubmed.ncbi.nlm.nih.gov/25758235
Publikováno v:
International Journal of Biotechnology. 9:332
Ebola Virus (EBOV) presents a challenge for vaccine development because immune correlates of protection in humans are not well known. In earlier studies we developed a concept of local similarity which refers to resemblance of structural patterns of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::28efb23356294bda48509cdaab2256e0
https://doi.org/10.1504/ijbt.2007.014251
https://doi.org/10.1504/ijbt.2007.014251
Autor:
Marina S. Fisher, Vasily V. Kurilin, Aleksey S. Bulygin, Julia A. Shevchenko, Julia G. Philippova, Oleg S. Taranov, Elena K. Ivleva, Amir Z. Maksyutov, Sergey V. Sennikov
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionRestoring immune tolerance is a promising area of therapy for autoimmune diseases. One method that helps restore immunological tolerance is the approach using tolerogenic dendritic cells (tolDCs). In our study, we analyzed the effectivene
Externí odkaz:
https://doaj.org/article/42e16c27c5ff4b72952b0739975c342d
Autor:
Julia A. Shevchenko, Julia A. Lopatnikova, Julia N. Khantakova, Alexander N. Silkov, Maria S. Kuznetsova, Vasiliy V. Kurilin, Amir Z. Maksyutov, Sergey V. Sennikov
Publikováno v:
Frontiers in Bioscience-Landmark, Vol 27, Iss 6, p 170 (2022)
Background: A search for efficient graft rejection modulation techniques for the promotion of durable engraftment remains to be a matter of close study all over the world. Despite the variety of immunosuppressive drugs, the schemes currently used sho
Externí odkaz:
https://doaj.org/article/35dd73e777db479f8fc2b18b8aa5b3b1
Autor:
Sergey V. Sennikov, Valeriy P. Tereshchenko, Vasiliy V. Kurilin, Julia A. Shevchenko, Julia A. Lopatnikova, Alexander N. Silkov, Amir Z. Maksyutov, Maria S. Kuznetsova, Nadezda Y. Knauer, Aleksey S. Bulygin, Julia N. Khantakova
Publikováno v:
Journal of Immunology Research, Vol 2020 (2020)
Background. Nonspecific immunosuppressive therapy for graft rejection and graft-versus-host disease (GVHD) is often accompanied by severe side effects such as opportunistic infections and cancers. Several approaches have been developed to suppress tr
Externí odkaz:
https://doaj.org/article/e59fca1567f749afbedf4ec50e8ed796